GP3269

Overview

GP3269 is a selective and orally active human adenosine kinase ( AK ) inhibitor with an IC 50 of 11 nM against human adenosine kinase . GP3269 increases adenosine levels at epileptic foci, activates A1 receptors on excitatory neurons, and exhibits anticonvulsant activity in rats. GP3269 does not induce hemodynamic effects including changes in blood pressure or heart rate in rats. GP3269 can be used for epilepsy-related research.

Application

Products | Products > Disease Areas > Neurological, Eye or Ear Disease | Products > Signaling Pathways > Metabolic Enzyme/Protease | Products > Signaling Pathways > Neuronal Signaling | Products > Research Areas > Neurological Disease | Products > Signaling Pathways > Adenosine Kinase

Product Information

• Catalog No.: HY-19259
• CAS No.: 186393-42-0
• Molecular Formula: C23H21FN4O3
• Molecular Weight: 420.44
• Purity: 99.98%
• Storage: Please store the product under the recommended conditions in the Certificate of Analysis.

Source

Original product source